• /search
  • Features
  • Create a Podcast
  • Spreaker
  • Plans & Pricing
  • Listen
  • Login Sign up
  • Podcast Distribution
  • Podcast Monetization
  • Podcast Analytics
  • Enterprise Podcasting
  • Podcast Recording App
  • Podcast App
  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Discover more
  • Features
    • Podcast Distribution
    • Podcast Monetization
    • Podcast Analytics
    • Enterprise Podcasting
    • Podcast Recording App
    • Podcast App
  • Create a Podcast
  • Plans & Pricing
  • Listen
    • Featured This Week
    • Spreaker's Prime Shows
    • Staff Picks
    • Crime
    • This NFL life 🏈
    • Discover more
  • Sign up SIGN IN
← Back to Explore

#rearrangement

Similar tags:

#cancergrace #grace #alk #gracecast #mutation
  • Dr. Heather Wakelee: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Heather Wakelee: My App...

  • Dr. Geoffrey Oxnard on Translating the Benefits of Molecular Oncology More Broadly: The Tissue is the Issue

    Dr. Geoffrey Oxnard on Tran...

  • Highlights in Lung Cancer, 2012: ALK Inhibitors for Patients with ALK or ROS1 Gene Rearrangements (audio)

    Highlights in Lung Cancer, ...

  • Dr. Sarah Goldberg on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer

    Dr. Sarah Goldberg on the U...

  • Dr. Greg Riely on "I just found out I have an EGFR mutation, and I'm in the middle of chemo. What now?"

    Dr. Greg Riely on "I j...

  • Dr. Sarah Goldberg: What Methods Do I Use to Obtain Samples for Molecular Testing?

    Dr. Sarah Goldberg: What Me...

  • Dr. Geoffrey Oxnard: Are Patients or Payers Objecting to Repeat Biopsy?

    Dr. Geoffrey Oxnard: Are Pa...

  • Dr. Sarah Goldberg on "I Just Found Out I Have an EGFR Mutation, and I'm in the Middle of Chemo. What Now?"

    Dr. Sarah Goldberg on &quot...

  • Dr. Geoffrey Oxnard: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing

    Dr. Geoffrey Oxnard: For Wh...

  • Dr. Rosalyn Juergens on "I Just Found Out I Have an EGFR Mutation, and I'm in the Middle of Chemo. What Now?"

    Dr. Rosalyn Juergens on &qu...

  • Dr. David Spigel: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. David Spigel: My Approa...

  • Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Greg Riely: My Approach...

  • Highlights in Lung Cancer, 2012: ALK Inhibitors for Patients with ALK or ROS1 Gene Rearrangements (video)

    Highlights in Lung Cancer, ...

  • Dr. Rosalyn Juergens on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer

    Dr. Rosalyn Juergens on the...

  • Dr. Rosalyn Juergens on Managing Acquired Resistance to Targeted Therapies for Advanced NSCLC

    Dr. Rosalyn Juergens on Man...

  • What Molecular Markers Do You Prioritize for Molecular Testing in Advanced NSCLC, and Who do you Test?

    What Molecular Markers Do Y...

  • Dr. Heather Wakelee on "Which molecular marker tests do you seek?"

    Dr. Heather Wakelee on &quo...

  • Dr. Ravi Salgia on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Dr. Ravi Salgia on "Wh...

  • Dr. Rosalyn Juergens: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy

    Dr. Rosalyn Juergens: Recom...

  • Dr. David Spigel on the Utility of Molecular Marker Results in the Adjuvant Setting for Early Stage Non-Small Cell Lung Cancer

    Dr. David Spigel on the Uti...

  • Dr. Karen Kelly: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing

    Dr. Karen Kelly: My Approac...

  • Dr. Ravi Salgia: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?

    Dr. Ravi Salgia: For Which ...

  • ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (video)

    ASCO Lung Cancer Highlights...

  • Dr. Phil Bonomi: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?

    Dr. Phil Bonomi: For Which ...

  • Dr. Greg Riely on "Which patients do you send molecular marker testing for, and what tests do you seek?"

    Dr. Greg Riely on "Whi...

  • Dr. Rosalyn Juergens: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?

    Dr. Rosalyn Juergens: How D...

  • Living with Lung Cancer

    Living with Lung Cancer

  • Can or Will Specific Molecular Characteristics Help Determine Which ALK Inhibitor to Choose?

    Can or Will Specific Molecu...

  • Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors?

    Are There Clinically Signif...

  • New Ideas and New Treatment Options for Acquired Resistance for ALK/ROS1

    New Ideas and New Treatment...

  • ROS-1 Rearrangements: What Are They?

    ROS-1 Rearrangements: What ...

  • Crizotinib for First Line Treatment of ALK or ROS1 Rearrangements

    Crizotinib for First Line T...

  • Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

    Timing of Second Generation...

  • Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC

    Ceritinib and Other Second ...

  • ALK Rearrangements: What Are They, and Who Has Them?

    ALK Rearrangements: What Ar...

  • TWiV #161 - Concerto in B

    TWiV #161 - Concerto in B

More Loading
Spreaker logo
  • Plans & Pricing
  • About Us
  • Voxnest
  • Blog
  • Careers
  • Press
  • Choose Language

For Podcasters and Editors

  • Enterprise Podcasting
  • Podcast Monetization
  • Podcast Analytics
  • Podcast Distribution

Tools for Podcasters

  • How to Start a Podcast
  • Spreaker Store
  • Spreaker Studio App
  • Spreaker Support

For Listeners

  • Spreaker Podcast App

Other Pages

  • Terms
  • Privacy

Top Categories

  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Discover more

Top Categories

  • Featured This Week
  • Spreaker's Prime Shows
  • Staff Picks
  • Crime
  • This NFL life 🏈
  • Discover more

Social

  • Facebook icon Facebook
  • Twitter icon Twitter
  • Linkedin icon LinkedIn
  • Instagram icon Instagram
iAB member badge

    Other Pages

  • Terms
  • Privacy

Social

Facebook icon Facebook
Twitter icon Twitter
Linkedin icon LinkedIn
Instagram icon Instagram
iAB member
Copyright 2021 - Spreaker Inc. a Voxnest Company - Create a Podcast - New York, NY
Privacy
Terms